UnitedHealth Group (UNH) Fundamentals 2026 — P/E 32.6x, Revenue Analysis | SniperIQ
UnitedHealth Group (UNH) is a US-listed Healthcare company in Medical - Healthcare Plans with a market capitalization of
UnitedHealth Group (UNH) has a market capitalization of approximately
UnitedHealth Group's trailing twelve-month P/E ratio is 32.6x, with a price-to-book (P/B) of 3.8x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
UnitedHealth Group runs a net profit margin of 2.7%, a gross margin of 18.8%, and an operating margin of 4.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
UnitedHealth Group reported revenue of $447.6B for fiscal year 2025, with net income of
UnitedHealth Group offers a trailing dividend yield of about 2.1%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
UnitedHealth Group carries a debt-to-equity ratio of 0.75x and a current ratio of 0.80x, with a market beta of 0.63. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For UnitedHealth Group (UNH) the key facts are: market cap
Get UnitedHealth Group's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.